<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0082">
 <element-citation publication-type="journal" id="sbref0082">
  <person-group person-group-type="author">
   <name>
    <surname>Hirokawa</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Arnold</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nakajima</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zalcberg</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Maruta</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance</article-title>
  <source>Cancer Biol. Ther.</source>
  <volume>4</volume>
  <issue>9</issue>
  <year>2005</year>
  <fpage>956</fpage>
  <lpage>960</lpage>
  <pub-id pub-id-type="pmid">16082189</pub-id>
 </element-citation>
</ref>
